Osaka, Japan

Toshiyuki Akiyama

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 95(Granted Patents)


Location History:

  • Osaka, JP (2014 - 2019)
  • Toyonaka, JP (2015 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations of Toshiyuki Akiyama

Introduction

Toshiyuki Akiyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of antiviral compounds, particularly in the development of novel medications targeting HIV. With a total of 13 patents to his name, Akiyama's work has the potential to impact public health positively.

Latest Patents

One of Akiyama's latest patents involves nitrogen-containing tricyclic derivatives that exhibit HIV replication inhibitory activity. This invention presents a novel compound with antiviral properties, specifically aimed at inhibiting HIV replication. The compound is characterized by a complex formula that includes various substituents, showcasing Akiyama's expertise in medicinal chemistry.

Career Highlights

Akiyama is currently associated with Shionogi & Company Limited, a leading pharmaceutical company known for its innovative research and development. His work at Shionogi has allowed him to focus on creating effective antiviral medications, contributing to the company's mission of improving global health.

Collaborations

Throughout his career, Akiyama has collaborated with notable colleagues, including Makoto Kawai and Kenji Tomita. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Toshiyuki Akiyama's contributions to antiviral research and his innovative patents highlight his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in HIV treatment and demonstrates the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…